Percutaneous Closure of Atrial Septal Defects Contraindications Are Hard to Find These Days∗ by Meier, Bernhard
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 4 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 5 . 0 2 . 0 0 7EDITORIAL COMMENTPercutaneous Closure of
Atrial Septal Defects
Contraindications Are Hard to Find These Days*Bernhard Meier, MDW ith respect to closure of atrial septaldefects (ASDs), there is a saying thatlarge ASDs need to be closed because
they are large and small ASDs need to be closed
because they are small. The saying was the fruit
of percutaneous device closure. When open heart
surgery was the only option, the indication bar was
set relatively high at a shunt index expressed as
Qp/Qs >1.5. This meant that the pulmonary blood
ﬂow volume per minute had to be >50% higher than
the systemic. Smaller shunts were by no means
acquitted from enlarging the right ventricle and
both atria or from allowing paradoxical embolism,
but their respective risks were deemed not to justify
the perils of open heart surgery. Now, this indication
threshold has become an oxymoron. There is the
possibility to close a small ASD in an outpatient
procedure with just local anesthesia of the groin
in <30 min and send the patient back a few hours
later to a completely normal life including sports.SEE PAGE 600In this issue of JACC: Cardiovascular Interventions,
a Japanese group lay to rest another possible contra-
indication for percutaneous ASD closure, namely, old
age (1). Looking at 3 age groups (50 to 59 years, 60 to 74
years, and $75 years), they conﬁrm that even in the
oldest age group, percutaneous ASD closure was safe
and beneﬁcial. Although the oldest age group had a
higher mortality than the younger ones, this was*Editorials published in JACC: Cardiovascular Interventions reﬂect the
views of the authors and do not necessarily represent the views of JACC:
Cardiovascular Interventions or the American College of Cardiology.
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proctor honoraria from St. Jude Medical.unrelated to the ASD or its closure. Exercise capacity,
heart failure markers, and echocardiographic param-
eters were signiﬁcantly improved in all age groups
examined. The average hospital stay was more than
3 days, but this was likely more due to Japanese cus-
toms than to the age of the patients or the treatment
applied.
The problem of atrial ﬁbrillation (AF) remains.
Somewhat surprisingly, the prevalence of permanent
AF was only 17%, i.e., 3% in the youngest, 14% in the
middle, and 42% in the oldest age group. The ex-
pected and also documented decrease in atrial size
may theoretically prevent a new occurrence of AF or
potentially revert some permanent AF. Conversely, it
is known that device closure may trigger AF. There is
no mention in this paper of a new onset of AF in the
roughly 3 years of follow-up. However, that does not
mean that it did not occur. It may simply not have
been taken for an event serious enough to be re-
ported. Nevertheless, it may be worthwhile to focus
on AF in the elderly. AF is the most feared compli-
cation of an ASD and the most common reason for
signiﬁcant morbidity or mortality. Surgical closure
after the age of 25 years appeared not to decrease
the occurrence of AF over long-term follow-up in
a 20-year-old report (2). Similarly, device ASD closure
did not inﬂuence permanent AF at any age but
seemed to reduce the incidence of paroxysmal AF in
younger patients (3). A review of a respective
comparative trial attested to both surgical and trans-
catheter closure, a signiﬁcant beneﬁt regarding atrial
tachycardia. Surgery, but not using a transcatheter
technique, also achieved ayu signiﬁcant reduction
of AF (4).
The authors of this seminal paper state that
physicians cannot decide whether transcatheter ASD
closure should be performed in older patients or not
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608because of the lack of scientiﬁc evidence.”
That problem has been taken care of by their paper,
removing the last remaining doubts after similar
previous publications (3,5). The fact that percuta-
neous device closure can be at least tried with virtu-
ally all anatomic variations of an ASD secundum
(perhaps except those larger than 35 mm by trans-
esophageal echocardiography) invites offering this
therapy to all patients afﬂicted. Closures of small
ASDs will work virtually without exceptions. With
larger shunts, the worst to be expected is a failure to
securely and correctly implant the device. If the de-
vice is not yet released from the deployment cable, it
can be withdrawn. It will usually not be billed for by
the manufacturer but rather replaced at no cost with
an identical device according to the terms of a
worldwide safety policy. If poor hemodynamic toler-
ance of the shunt closure is feared, the device can be
left in place for 30 min or longer before being de-
tached. During this time, cardiac pressure assess-
ments can be made, and the patient can be asked for
any shortness of breath in the typical supine posi-
tion. Should such symptoms only occur hours after
the intervention, the device can fairly easily be
removed percutaneously for a couple of days afterimplantation. In the current report and in my per-
sonal experience, all devices were tolerated and none
had to be removed at any time. In the rare case of
device embolization, this is usually well tolerated.
Large devices generally do not leave the ventricle
they end up in. Smaller devices can be retrieved from
the aorta or pulmonary artery where they typically
get stuck. However, in some cases, surgical removal
with simultaneous ASD closure may be required (6).
This may pose a problem in an otherwise inoperable
patient in whom percutaneous device closure of an
ASD is attempted. However, this situation has yet to
be reported.
All things considered, it comes as no surprise that
ASD device closure has virtually supplanted surgical
interventions over the past 15 years (7). Moreover, we
are slowly but surely running out of contraindica-
tions, although even very recently a respective list
was published (8). Observing such a list may not
necessarily be in the best interest of the patient.
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